Ultragenyx Pharmaceutical Inc(RARE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RARE Ultragenyx Pharmaceutical Inc

休市中 08-15 16:00:00 EDT

29.69

+0.68

+2.34%

盘后29.72

+0.03+0.10%

19:59 EDT

最高30.10	最低29.07	成交量135.05万
今开29.13	昨收29.01	日振幅3.57%
总市值28.56亿	流通市值27.55亿	总股本9,620万
成交额4,005万	换手率1.46%	流通股本9,280万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RARE","market":"US","secType":"STK","nameCN":"Ultragenyx Pharmaceutical Inc","latestPrice":29.69,"timestamp":1755288000000,"preClose":29.01,"halted":0,"volume":1350458,"hourTrading":{"tag":"盘后","latestPrice":29.72,"preClose":29.69,"latestTime":"19:59 EDT","volume":33801,"amount":1003681.28,"timestamp":1755302343073},"delay":0,"floatShares":92796237,"shares":96198609,"eps":-5.521909,"marketStatus":"休市中","change":0.68,"latestTime":"08-15 16:00:00 EDT","open":29.13,"high":30.1,"low":29.065,"amount":40045040.593314,"amplitude":0.035677,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.521909,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1755504000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1391144400000,"exchange":"NASDAQ","adjPreClose":29.01,"preHourTrading":{"tag":"盘前","latestPrice":29.07,"preClose":29.01,"latestTime":"09:29 EDT","volume":42831,"amount":1242590.614218,"timestamp":1755264599999},"postHourTrading":{"tag":"盘后","latestPrice":29.72,"preClose":29.69,"latestTime":"19:59 EDT","volume":33801,"amount":1003681.28,"timestamp":1755302343073},"volumeRatio":0.9107663961780498,"impliedVol":0.4869,"impliedVolPercentile":0.304},"requestUrl":"/m/hq/s/RARE","defaultTab":"news","newsList":[{"id":"2558681744","title":"Ultragenyx Pharmaceutical Inc.2025财年第二财季实现净利润-1.15亿美元，同比增加12.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558681744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558681744?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:01","pubTimestamp":1754841695,"startTime":"0","endTime":"0","summary":"8月11日，Ultragenyx Pharmaceutical Inc.公布财报，公告显示公司2025财年第二财季净利润为-1.15亿美元，同比增加12.88%；其中营业收入为1.66亿美元，同比增加12.93%，每股基本收益为-1.17美元。机构评级：截至2025年8月11日，当前有21家机构对Ultragenyx Pharmaceutical Inc.目标价做出预测，其中目标均价为84.62美元，其中最低目标价为34.00美元，最高目标价为128.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000348a6de081a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000348a6de081a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RARE"],"gpt_icon":0},{"id":"2557308749","title":"Ultragenyx Pharmaceutical Inc.盘中异动 大幅下跌5.05%报27.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557308749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557308749?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:11","pubTimestamp":1754489513,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时11分，Ultragenyx Pharmaceutical Inc.股票出现波动，股价大幅下跌5.05%。截至发稿，该股报27.46美元/股，成交量23.2957万股，换手率0.25%，振幅4.70%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojorvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508062211539737991d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508062211539737991d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2554720516","title":"派盾：SuperRare 遭遇攻击，损失约 73 万美元的 RARE","url":"https://stock-news.laohu8.com/highlight/detail?id=2554720516","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554720516?lang=zh_cn&edition=full","pubTime":"2025-07-28 17:41","pubTimestamp":1753695698,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据派盾监测，NFT 市场 SuperRare 遭遇攻击，损失价值约 73 万美元的 RARE 代币。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2193759","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2554727850","title":"PeckShield：SuperRare遭遇攻击，损失约73万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554727850","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554727850?lang=zh_cn&edition=full","pubTime":"2025-07-28 17:34","pubTimestamp":1753695275,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/PeckShieldAlert/status/1949764035408527414","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2551193127","title":"Ultragenyx Pharmaceutical Inc.盘中异动 大幅跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551193127","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551193127?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:46","pubTimestamp":1752590772,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时46分，Ultragenyx Pharmaceutical Inc.股票出现异动，股价快速跳水5.06%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Kairos Pharma, Ltd.、Polyrizon Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为1532.47%、1504.37%、1067.98%，振幅较大的相关个股有Kairos Pharma, Ltd.、Polyrizon Ltd.、Protagenic Therapeutics Inc C/Wts 26/04/2026 ，振幅分别为109.47%、75.50%、66.39%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojorvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071522461395439b1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071522461395439b1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2550966544","title":"Ultragenyx Pharmaceutical Inc.盘中异动 股价大跌5.02%报29.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550966544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550966544?lang=zh_cn&edition=full","pubTime":"2025-07-12 02:53","pubTimestamp":1752260000,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日02时53分，Ultragenyx Pharmaceutical Inc.股票出现波动，股价快速下跌5.02%。截至发稿，该股报29.48美元/股，成交量324.902万股，换手率3.44%，振幅4.45%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojorvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712025320953f1bc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712025320953f1bc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2550265656","title":"Ultragenyx Pharmaceutical Inc.盘中异动 早盘股价大涨5.00%报41.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550265656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550265656?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:18","pubTimestamp":1752070724,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时18分，Ultragenyx Pharmaceutical Inc.股票出现异动，股价急速拉升5.00%。截至发稿，该股报41.39美元/股，成交量22.1636万股，换手率0.23%，振幅4.16%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体涨幅为1.28%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojorvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221844a4408d84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221844a4408d84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2543175634","title":"Ultragenyx Pharmaceutical Inc.盘中异动 股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543175634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543175634?lang=zh_cn&edition=full","pubTime":"2025-06-14 02:35","pubTimestamp":1749839743,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日02时35分，Ultragenyx Pharmaceutical Inc.股票出现波动，股价急速下挫5.12%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体跌幅为0.84%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojorvi 和 Mepsevii。Crysvita 用于治疗成人和 1 岁及以上儿童患者的 X 连锁低磷血症 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614023543951b6ff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614023543951b6ff8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2543546636","title":"Ultragenyx Pharmaceutical Inc.盘中异动 快速上涨5.01%报39.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543546636","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543546636?lang=zh_cn&edition=full","pubTime":"2025-06-12 23:52","pubTimestamp":1749743538,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日23时52分，Ultragenyx Pharmaceutical Inc.股票出现波动，股价急速上涨5.01%。截至发稿，该股报39.39美元/股，成交量48.882万股，换手率0.52%，振幅5.95%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojorvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506122352189519af4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506122352189519af4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2540079113","title":"Ultragenyx Pharmaceutical Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540079113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540079113?lang=zh_cn&edition=full","pubTime":"2025-06-02 22:58","pubTimestamp":1748876290,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日22时58分，Ultragenyx Pharmaceutical Inc.股票出现异动，股价快速拉升5.02%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体涨幅为1.25%。其相关个股中，Lyra Therapeutics, Inc.、Oragenics Inc.、Immatics N V C/Wts 01/07/2025 涨幅较大，Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为1512.69%、1037.09%、332.85%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Oragenics Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为248.28%、98.58%、80.43%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojorvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602225810976e8fba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602225810976e8fba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2537958430","title":"Ultragenyx Pharmaceutical Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537958430","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537958430?lang=zh_cn&edition=full","pubTime":"2025-05-22 01:24","pubTimestamp":1747848251,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日01时24分，Ultragenyx Pharmaceutical Inc.股票出现波动，股价大幅跳水5.01%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体跌幅为1.10%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Apollomics Inc C/Wts 01/04/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Polyrizon Ltd.、Aptevo Therapeutics Inc.、Nucana Plc较为活跃，换手率分别为9629.16%、1431.63%、1082.12%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Aptevo Therapeutics Inc.，振幅分别为659.17%、232.26%、131.27%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojorvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522012411a4871892&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522012411a4871892&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2534430788","title":"大摩：维持Ultragenyx Pharmaceutical评级，由增持调整至增持评级, 目标价由64.00美元调整至65.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534430788","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534430788?lang=zh_cn&edition=full","pubTime":"2025-05-10 00:14","pubTimestamp":1746807283,"startTime":"0","endTime":"0","summary":"大摩：维持Ultragenyx Pharmaceutical(RARE.US)评级，由增持调整至增持评级, 目标价由64.00美元调整至65.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051000175894f1f652&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051000175894f1f652&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RARE"],"gpt_icon":0},{"id":"2533132447","title":"Ultragenyx Pharmaceutical Inc.盘中异动 股价大涨5.21%报35.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533132447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533132447?lang=zh_cn&edition=full","pubTime":"2025-05-08 22:43","pubTimestamp":1746715404,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日22时43分，Ultragenyx Pharmaceutical Inc.股票出现异动，股价大幅上涨5.21%。截至发稿，该股报35.16美元/股，成交量22.2524万股，换手率0.24%，振幅5.86%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体跌幅为3.21%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojorvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508224324a476e124&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508224324a476e124&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2529528676","title":"Ultragenyx Pharmaceutical Inc.盘中异动 股价大涨5.07%报37.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529528676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529528676?lang=zh_cn&edition=full","pubTime":"2025-04-24 03:08","pubTimestamp":1745435291,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日03时08分，Ultragenyx Pharmaceutical Inc.股票出现波动，股价大幅拉升5.07%。截至发稿，该股报37.73美元/股，成交量51.7451万股，换手率0.55%，振幅4.27%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojorvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042403081197427b27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042403081197427b27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2514693738","title":"Ultragenyx Pharmaceutical Inc.盘中异动 快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514693738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514693738?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:31","pubTimestamp":1740594704,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时31分，Ultragenyx Pharmaceutical Inc.股票出现异动，股价快速上涨5.02%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojolvi 和 Mepsevii。Mepsevii 适用于儿童和成人患者，用于治疗粘多糖贮积症 VII。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227023144a2552d5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227023144a2552d5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2512654151","title":"Ultragenyx Pharmaceutical Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512654151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512654151?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:42","pubTimestamp":1739889762,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时42分，Ultragenyx Pharmaceutical Inc.股票出现波动，股价急速拉升5.00%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为303.06%、107.94%、86.68%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.、Pulmatrix, Inc.，振幅分别为34.04%、26.83%、23.16%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojolvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182242429889ff3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182242429889ff3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2511696720","title":"Ultragenyx Pharmaceutical Inc.盘中异动 股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511696720?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:33","pubTimestamp":1739543638,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时33分，Ultragenyx Pharmaceutical Inc.股票出现异动，股价急速上涨5.28%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1064.90%、373.59%、342.61%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virpax Pharmaceuticals, Inc.、Theratechnologies Inc.，振幅分别为20.20%、19.73%、18.33%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojolvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422335898858a18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422335898858a18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"1121072706","title":"Ultragenyx Pharmaceutical 2024年第四季度GAAP每股亏损$(1.39)逊于预期$(1.29)，销售额$164.877M逊于预估$155.393M","url":"https://stock-news.laohu8.com/highlight/detail?id=1121072706","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121072706?lang=zh_cn&edition=full","pubTime":"2025-02-14 05:04","pubTimestamp":1739480664,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical公布季度每股亏损 $，逊于分析师一致预期的 $，相差7.75%。与去年同期的 $127.392M 相比，这一销售额下降了100.00%。以上内容来自Benzinga Earnings专栏，原文如下：Ultragenyx Pharmaceutical  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 7.75 percent. This is a 8.55 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $164.877 which missed the analyst consensus estimate of $155.393 million by 100.00 percent.  This is a 100.00 ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ultragenyx Pharmaceutical 2024年第四季度GAAP每股亏损$(1.39)逊于预期$(1.29)，销售额$164.877M逊于预估$155.393M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE"],"gpt_icon":0},{"id":"2505042797","title":"Ultragenyx Pharmaceutical Inc.盘中异动 下午盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505042797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505042797?lang=zh_cn&edition=full","pubTime":"2025-01-24 02:45","pubTimestamp":1737657924,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日02时45分，Ultragenyx Pharmaceutical Inc.股票出现波动，股价急速上涨5.03%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Nutriband Inc.涨幅较大，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为6249.65%、3894.06%、697.17%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为948.57%、144.39%、84.55%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojolvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124024524960e7305&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124024524960e7305&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2503502086","title":"Ultragenyx Pharmaceutical Inc.盘中异动 下午盘大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503502086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503502086?lang=zh_cn&edition=full","pubTime":"2025-01-15 02:16","pubTimestamp":1736878561,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日02时16分，Ultragenyx Pharmaceutical Inc.股票出现异动，股价大幅下挫5.00%。Ultragenyx Pharmaceutical Inc.股票所在的生物技术行业中，整体跌幅为0.61%。其相关个股中，Eterna Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为1018.50%、562.41%、415.53%，振幅较大的相关个股有Eterna Therapeutics Inc.、Matinas Biopharma Holdings, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为170.74%、69.81%、69.33%。Ultragenyx Pharmaceutical Inc.公司简介：Ultragenyx Pharmaceutical Inc 是一家总部位于美国的生物制药公司。该公司的药品组合包括 Crysvita、Dojolvi 和 Mepsevii。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115021601abaade7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115021601abaade7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RARE","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ultragenyx.com","stockEarnings":[{"period":"1week","weight":0.0781},{"period":"1month","weight":0.0871},{"period":"3month","weight":-0.1662},{"period":"6month","weight":-0.3012},{"period":"1year","weight":-0.4261},{"period":"ytd","weight":-0.2943}],"compareEarnings":[{"period":"1week","weight":0.0098},{"period":"1month","weight":0.0308},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1634},{"period":"ytd","weight":0.0979}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ultragenyx Pharmaceutical Inc.于2010年4月22日成立，是一家处于发展阶段的生物科技企业，公司随后于2011年6月在特拉华州重新注册成立。公司专注于新型产品的鉴定、收购、开发与商业化，该产品主要用于治疗罕见和极罕见的疾病，产品最初目标是用于治疗严重的，令人衰弱的代谢基因类疾病。公司目前用于治疗遗传性包涵体肌病患者的缓释唾液酸正处于临床试验第二阶段，该疾病是一种渐进式的肌肉萎缩疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.014805},{"month":2,"riseRate":0.583333,"avgChangeRate":0.072766},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.056113},{"month":4,"riseRate":0.333333,"avgChangeRate":0.004951},{"month":5,"riseRate":0.416667,"avgChangeRate":0.029499},{"month":6,"riseRate":0.75,"avgChangeRate":0.064977},{"month":7,"riseRate":0.416667,"avgChangeRate":0.000441},{"month":8,"riseRate":0.583333,"avgChangeRate":0.034319},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.060177},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.075162},{"month":11,"riseRate":0.454545,"avgChangeRate":0.039977},{"month":12,"riseRate":0.636364,"avgChangeRate":0.047966}],"exchange":"NASDAQ","name":"Ultragenyx Pharmaceutical Inc","nameEN":"Ultragenyx Pharmaceutical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.8","shortVersion":"4.34.8","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ultragenyx Pharmaceutical Inc(RARE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ultragenyx Pharmaceutical Inc(RARE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ultragenyx Pharmaceutical Inc,RARE,Ultragenyx Pharmaceutical Inc股票,Ultragenyx Pharmaceutical Inc股票老虎,Ultragenyx Pharmaceutical Inc股票老虎国际,Ultragenyx Pharmaceutical Inc行情,Ultragenyx Pharmaceutical Inc股票行情,Ultragenyx Pharmaceutical Inc股价,Ultragenyx Pharmaceutical Inc股市,Ultragenyx Pharmaceutical Inc股票价格,Ultragenyx Pharmaceutical Inc股票交易,Ultragenyx Pharmaceutical Inc股票购买,Ultragenyx Pharmaceutical Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ultragenyx Pharmaceutical Inc(RARE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ultragenyx Pharmaceutical Inc(RARE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}